SLEEPBIOTICS

Serial Number 90801832
606

Registration Progress

Application Filed
Jun 29, 2021
Under Examination
Jul 28, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Trademark Image

SLEEPBIOTICS

Basic Information

Serial Number
90801832
Filing Date
June 29, 2021
Published for Opposition
May 31, 2022
Abandonment Date
June 30, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 30, 2025
Classes
005

Rights Holder

BIOHM HEALTH INC.

03
Address
SUITE 100
425 LITERARY RD.
CLEVELAND, OH 44113

Ownership History

Biohm Health LLC

Original Applicant
16
Cleveland, OH

Biohm Health LLC

Owner at Publication
16
Cleveland, OH

BIOHM HEALTH INC.

New Owner After Publication #1
03
CLEVELAND, OH

Legal Representation

Attorney
Brian E. Turung

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Oct 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 30, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 13, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 27, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 15, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 15, 2024 PGEX O PETITION GRANTED - EXTENSION REQUEST FILED Loading...
Jul 15, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
May 30, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 29, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 28, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 28, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 30, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 30, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
May 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2022 NEWN I NEW NOA TO ISSUE Loading...
Jul 28, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 26, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 22, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 10, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 11, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; dietary supplements for medical use, namely metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplements and vitamins and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome

Additional Information

Pseudo Mark
SLEEP BIOTICS

Classification

International Classes
005